Plasma CRP and soluble urokinase plasminogen activator receptor (suPAR), which indicates inflammatory activity, demonstrated significant correlations with newly diagnosed cancer during follow-up after adjusting for age and sex. The gene discussed is CRP; the disease is cancer.